Walker Karen Marie

Track

Insider profile

Walker Karen Marie's trades of Kyverna Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
193.77
Quantity 19,252
Value US$140,552
Transaction date
Proposed sale
Price
8.78
Quantity 23,998
Value US$210,702
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-17 2026-04-17
PrS Proposed sale
43,942
230.47
US$1,417,058 		43,942 230.47 US$1,417,058
2026-04-14 2026-04-14
PrS Proposed sale
19,252
193.77
US$140,552 		19,252 193.77 US$140,552
2025-12-17 2025-12-15
PlS Planned sale
85,711 -15.0%
211.83
US$1,633,023 		85,711 -15.0% 211.83 US$1,633,023
2025-12-15 2025-12-15
PrS Proposed sale
23,998
8.78
US$210,702 		23,998 8.78 US$210,702